Pulmosil 10mg Injection

Pulmosil 10mg Injection contains sildenafil as its active component. This medication is indicated for the treatment of pulmonary arterial hypertension (PAH) in adults and children. PAH is characterised by elevated blood pressure in the arteries supplying blood from the heart to the lungs. Sildenafil belongs to a class of drugs known as phosphodiesterase type 5 (PDE-5) inhibitors, which includes agents such as Viagra (sildenafil) used for erectile dysfunction. Patients with PAH commonly present with dyspnoea and reduced exercise tolerance resulting from increased pulmonary arterial pressure. Pulmosil 10mg Injection improves exercise capacity by reducing strain on the heart and lungs, enabling patients with PAH to undertake physical activities with greater ease. PAH is a chronic condition that can substantially affect daily functioning and quality of life. By managing disease symptoms and progression, this medication can improve quality of life for patients with PAH. It is among the limited medications approved for paediatric PAH, representing an important therapeutic option for children with this condition. Pulmosil 10mg Injection can cause transient reduction in blood pressure, particularly when combined with other antihypertensive agents or in patients with underlying hypotension. Caution is advised in patients with hypotension. Pre-existing cardiac conditions must be disclosed to the healthcare provider prior to initiating treatment. Patients with severe hepatic or renal impairment may require dose modification or close monitoring during therapy. Pulmosil 10mg Injection is contraindicated with concurrent use of nitrates (nitroglycerin, isosorbide dinitrate, isosorbide mononitrate) or other medications containing nitric oxide donors, as this combination may cause severe hypotension.

Pulmosil 10mg uses are: Pulmonary arterial hypertension

This medication works by relaxing the blood vessels in the lungs, reducing the pressure in the pulmonary arteries, and improving blood flow. This helps to alleviate symptoms of PAH and improve exercise capacity.

The injection is typically administered in a hospital or clinical setting under the supervision of a healthcare professional. The injection is given intravenously (IV) through a vein. Your healthcare provider will determine the dosage and infusion rate of injection based on your condition and response to the medication. The injection should be prepared and administered by trained healthcare personnel to ensure proper dosing and safety.

Pulmosil injection side effects like all medications, although not everyone will experience them. Serious: Sudden vision loss or vision changes Sudden hearing loss or changes in hearing Prolonged and painful erection (priapism) Severe allergic reactions (rash, itching, swelling of the face, lips, tongue, or throat, difficulty breathing) Chest pain or heart-related symptoms Common: Headache Flushing (reddening and warming of the face and skin) Upset stomach or indigestion Nasal congestion Dizziness or lightheadedness Diarrhea Nausea Back pain Muscle pain